Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the ACR Rheumatology Informatics System for Effectiveness registry.

In this large US-based study of patients with PMR receiving rheumatology care, only a minority of patients were prescribed steroid-sparing agents during the first 24 months of follow-up; most patients remained on glucocorticoids past 1 year. Further identification of patients who would benefit of steroid-sparing agents and timing of steroid-sparing agent initiation is needed.